85 results about "Dermatitis eczema" patented technology

The invention discloses a traditional Chinese medicine composition for treating dermatitis and eczema of infants, which consists of oral medicines and externally applied medicines, the oral medicines include 5 to 10 parts of red-rooted salvia root, 5 to 10 parts of suberect spatholobus stem, 5 to 10 parts of the seed of Job stears, 5 to 10 parts of Chinese angelica, 5 to 10 parts of astragalus root, 5 to 15 parts of bighead atractylodes rhizome, 5 to 10 parts of glabrous greenbrier rhizome, 5 to 10 parts of honeysuckle flower, 5 to 10 parts of Philippine violet herb, 5 to 10 parts of Japanese honeysuckle stem, 5 to 10 parts of Chinese wolfberry root bark, 5 to 10 parts of Chinese starjasmine stem and 5 to 15 parts of whiteflower patrinia herb, and the externally applied medicines include 5 to 15 parts of common cnidium fruit, 5 to 15 parts of natural indigo, 10 to 15 parts of spreading hedyotis herb, 10 to 15 parts of cortex dictamnt, 5 to 15 parts of clematis root, 5 to 15 parts of parslane herb, 5 to 15 parts of lightyellow sophora root, 10 to 15 parts of redroot gromwell root, 5 to 15 parts of dried alum, 10 to 15 parts of heartleaf houttuynia herb and 5 to 15 parts of amur corktree bark. The traditional Chinese medicine composition can be easily prepared, the cost is low, the Chinese medicinal materials with different medicinal properties are adopted and scientifically prepared, and the traditional Chinese medicine composition does not have any stimulating effect on the intestines, stomachs and skin of infants, and is safe and effective.

The invention provides a novel method of applying matrine to treating eczematous dermatitis, belonging to the field of medicines. The method is characterized by 1. adopting intravenous drip of matrine to treat eczematous dermatitis, 2. adopting intravenous drip of matrine to treat eczematous dermatitis in combination with oral administration of antihistamines, 3. adopting oral administration of matrine tablets or capsules to treat eczematous dermatitis and 4. applying matrine ointments to the wounded parts to externally treat eczematous dermatitis. Compared with the existing medicines and methods for treating eczematous dermatitis, the novel method has the effects that unexpected curative effects can be obtained and the cure rate is above 75%. The new method is an innovative idea of holistic treatment for treating eczematous dermatitis and has great medical significance.

The invention, relating to the technical field of medicine, provides a Chinese-medicinal compound lotion for treating dermatitis eczema and a preparation method thereof. The component proportion of the lotion is: 50-70g of sophora flavescens, 40-60g of common cnidium fruit, 20-40g of phellodendron, 25-35g of Chinese angelica, 15-25g of Ligusticum wallichii, 15-30g of rheum officinale, 3-6g of borneol, and 0.1wt% of antiseptic ethylparaben. The preparation method comprises the following steps: 1) preparing an extract of sophora flavescens, common cnidium fruit and phellodendron; 2) preparing an extract of Chinese angelica, Ligusticum wallichii and rheum officinale; 3) mixing the extracts obtained by step 1) and 2), adding borneol according to the proportion and 0.1wt% of antiseptic ethylparaben, adding water until the amount of the mixture reaches to 1000ml for dilution, and sub-packaging. The lotion can avoid the irritation on gastrointestinal tracts by oral administration, reduce the blood concentration of body and reduce side effects through the transdermal drug delivery. The preparation method is simple, and the lotion is easy to operate and improves the compliance of medicine. The invention provides a novel medicinal preparation for treating dermatitis eczema.

Disclosed are a pharmaceutical composition comprising kushenin and glycyrrhizic acid or derivatives thereof and the use of the composition in preparing a drug for preventing and treating dermatitis and eczema, wherein the weight ratio of the kushenin or a derivative thereof to the glycyrrhizic acid or a derivative thereof is 10:1-1:10.

Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

The invention discloses a spray type medical cold compress gel for treating dermatitis and eczema. The spray type medical cold compress gel comprises, by weight parts, 7-20 parts of isothiocyanate, 5-15 parts of peppermint extract, 3-8 parts of sappan wood, 5-10 parts of peel extract, 0.5-1.5 parts of 2-octenyl succinic anhydride, 1-2 parts of nano titanium oxide, 1-5 parts of polyvinyl alcohol, 2-4 parts of ethyl p-hydroxybenzoate, 1-2 parts of sodium carboxymethyl cellulose, 2-6 parts of glycerin, 10-20 parts of ethanol, and 15-33 parts of water. The invention also discloses a method for preparing the medical cold compress gel. The gel is of a spray type, can have dual effects of quick itching relief and efficient repair, and is good in effect of treating dermatitis and eczema in adultsand children and small in toxic and side effects.

Disclosed are compositions and their use for the treatment of human skin, particularly facial skin, to alleviate the symptoms of cosmetic or dermatologic skin conditions. The compositions include black willow bark extract, cat's claw extract, and dragon's blood extract. The compositions ameliorate skin conditions including acne, rosacea, blemish, dermatitis, eczema, or the like.

The invention provides an application of a urine keratin, type II cytoskeletal 1 (Keratin, type II cytoskeletal 1) protein and a polypeptide fragment thereof, and particularly relates to an application of the urine keratin, type II cytoskeletal 1 and the polypeptide fragment thereof in preparation of a preparation for detecting allergic diseases. The allergic diseases are also known as allergic diseases, and the typical allergic diseases (allergic diseases) comprise allergic rhinitis, bronchial asthma, allergic dermatitis, eczema, allergic conjunctivitis, allergic shock and the like, and are collectively known as allergic diseases below. Researches prove that compared with a healthy human group (normal control), the expression of the urine keratin, II type cytoskeleton 1 and the polypeptide fragment thereof in an allergic disease patient group is improved, and the urine keratin, II type cytoskeleton 1 and the polypeptide fragment thereof can be used for auxiliary diagnosis of allergic disease patients. The advantages of noninvasive acquisition, large-scale repeated sampling and convenient preservation of the urine sample are exerted, and the urine keratin, II-type cytoskeleton 1 and the polypeptide fragments thereof are detected by utilizing the urine sample.